StonvexLoading…
StonvexStonvexStonvexCore line items from HYNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 |
|---|---|---|
Revenue | $20.37M | $16.80M |
Operating Income | $8.92K | $-2.99M |
Net Income | $232.69K | $-1.96M |
EPS (Diluted) | $0.03 | Not available |
Total Assets | $489.38M | $449.51M |
Total Liabilities | $328.01M | $363.68M |
Cash & Equivalents | $47.60M | $15.33M |
Free Cash Flow OCF − CapEx | $201.99K | $-3.75M |
Shares Outstanding | 8.10M | Not available |